Request Deal Involvement

Cormorant Asset led a $125m Series A funding round in Chroma Medicine.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Principals

CHROMA MEDICINE

target

CHROMA MEDICINE

ATLAS VENTURE LP

bidder

ATLAS VENTURE LP

NEWPATH PARTNERS

bidder

NEWPATH PARTNERS

SOFINNOVA PARTNERS

bidder

SOFINNOVA PARTNERS

CORMORANT ASSET MANAGEMENT

bidder

CORMORANT ASSET MANAGEMENT

CASDIN CAPITAL

bidder

CASDIN CAPITAL

JANUS HENDERSON INVESTORS

bidder

JANUS HENDERSON INVESTORS

OMEGA FUNDS

bidder

OMEGA FUNDS

T. ROWE PRICE GROUP INC

bidder

T. ROWE PRICE GROUP INC

WELLINGTON MANAGEMENT

bidder

WELLINGTON MANAGEMENT

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite